The fight against cancer may have found an unexpected ally in the form of humble kitchen bacteria and a plant commonly used as a sweetener. Recent research from scientists in Japan has uncovered the potential anti-cancer properties of fermented stevia, a plant known for its calorie-free sweetness.
Pancreatic cancer, one of the most challenging cancers to treat, has a grim prognosis with less than 10% of patients surviving beyond five years. Conventional therapies like chemotherapy often fall short in providing a cure, leading researchers to explore alternative plant-based compounds for more effective and less toxic treatments.
Stevia, a leafy plant native to South America, is rich in bioactive compounds that have shown hints of anti-cancer and antioxidant activity in previous studies. However, unfermented stevia extracts have limited effectiveness in laboratory settings, requiring high doses to impact cancer cells.
Fermentation, a process known for its role in creating yogurt, kimchi, and sourdough bread, has been found to transform plant compounds into new bioactive molecules. Researchers at Hiroshima University experimented with fermenting stevia with a specific bacteria strain called Lactobacillus plantarum SN13T. This fermentation process produced a compound called chlorogenic acid methyl ester (CAME), which demonstrated stronger anti-cancer effects than raw stevia extract.
In lab tests, the fermented stevia extract showed promising results by causing pancreatic cancer cells to die while leaving healthy kidney cells unharmed. Further analysis revealed that CAME was responsible for this effect, working by blocking cancer cells at a specific phase of their life cycle and triggering apoptosis, a natural process where damaged cells self-destruct.
Fermented stevia extract also exhibited stronger antioxidant properties compared to its unfermented form, offering additional protection for healthy cells against oxidative stress. This finding aligns with previous research showcasing the enhanced health benefits of fermented soy and ginseng.
The selectivity of the compound in targeting cancer cells while sparing healthy ones is a significant breakthrough in cancer research. While the results are based on lab-grown cells and further studies on animals and humans are needed, the discovery holds promise for a natural, targeted, and cost-effective cancer therapy.
This research underscores the potential of everyday foods and their natural microbes as sources of new medicines. It also highlights the growing interest in microbial biotransformation, utilizing beneficial bacteria to create potent compounds from plants.
What started as a quest for a natural sweetener has evolved into a potential groundbreaking cancer therapy with fermented stevia. The study signifies a step towards a more effective and less toxic treatment for pancreatic cancer, offering hope for improved outcomes in the future.
